Anti-epidermal growth factor receptor conjugated mesoporous zinc oxide nanofibers for breast cancer diagnostics
- 17 March 2015
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 7 (16), 7234-7245
- https://doi.org/10.1039/c5nr00194c
Abstract
We report the fabrication of an efficient, label-free, selective and highly reproducible immunosensor with unprecedented sensitivity (femto-molar) to detect a breast cancer biomarker for early diagnostics. Mesoporous zinc oxide nanofibers (ZnOnFs) are synthesized by electrospinning technique with a fiber diameter in the range of 50–150 nm. Fragments of ZnOnFs are electrophoretically deposited on an indium tin oxide glass substrate and conjugated via covalent or electrostatic interactions with a biomarker (anti-ErbB2; epidermal growth factor receptor 2). Oxygen plasma treatment of the carbon doped ZnOnFs generates functional groups (–COOH, –OH, etc.) that are effective for the conjugation of anti-ErbB2. ZnOnFs without plasma treatment that conjugate via electrostatic interactions were also tested for comparison. Label-free detection of the breast cancer biomarker by this point-of-care device is achieved by an electrochemical impedance technique that has high sensitivity (7.76 kΩ μM−1) and can detect 1 fM (4.34 × 10−5 ng mL−1) concentration. The excellent impedimetric response of this immunosensor provides a fast detection (128 s) in a wide detection test range (1.0 fM–0.5 μM). The oxy-plasma treated ZnOnF immunoelectrode shows a higher association constant (404.8 kM−1 s−1) indicating a higher affinity towards the ErbB2 antigen compared to the untreated ZnOnF immunoelectrode (165.6 kM−1 s−1). This sensor is about an order of magnitude more sensitive than the best demonstrated in the literature based on different nanomaterials and about three orders of magnitude better than the ELISA standard for breast cancer biomarker detection. This proposed point-of-care cancer diagnostic offers several advantages, such as higher stability, rapid monitoring, simplicity, cost-effectiveness, etc., and should prove to be useful for the detection of other bio- and cancer markers.Keywords
This publication has 39 references indexed in Scilit:
- Novel Synthesis and Characterization of Mesoporous ZnO Nanofibers by Electrospinning TechniqueACS Sustainable Chemistry & Engineering, 2013
- Electrochemical immunosensor for label free epidermal growth factor receptor (EGFR) detectionBiosensors and Bioelectronics, 2013
- Mediator-free microfluidics biosensor based on titania–zirconia nanocomposite for urea detectionRSC Advances, 2012
- Electrochemical Detection of Anti-Breast-Cancer Agents in Human Serum by Cytochrome P450-Coated Carbon NanotubesSensors, 2012
- Cancer-Targeted Optical Imaging with Fluorescent Zinc Oxide NanowiresNano Letters, 2011
- Graphene‐Encapsulated Nanoparticle‐Based Biosensor for the Selective Detection of Cancer BiomarkersAdvanced Materials, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Cancer Biomarkers: Are We Ready for the Prime Time?Cancers, 2010
- Imaging Pancreatic Cancer Using Bioconjugated InP Quantum DotsACS Nano, 2009
- ErbB receptors: from oncogenes to targeted cancer therapiesJCI Insight, 2007